查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球實體瘤檢測市場規模研究與預測，按類型、按應用、按終端用途和區域分析
市場調查報告書
商品編碼
1290515

2023-2030年全球實體瘤檢測市場規模研究與預測，按類型、按應用、按終端用途和區域分析

Global Solid Tumor Testing Market Size study & Forecast, by Type, by Application, by End Use and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2022年全球實體瘤檢測市場價值約為254.7億美元，預計在2023-2030年預測期內將以超過7.0%的健康成長率成長。固體腫瘤的特點是不包括液體或囊腫的不受控制的細胞發展。對於腫瘤的早期診斷，實體瘤檢測被使用。儘管對實體瘤的生物學進行了大量研究，並開發了檢測實體瘤的測試方法，但它們仍然是死亡的主要原因之一。基因檢測和常規檢測是用於診斷實體瘤的兩種方法。由於癌症患病率上升和卵巢癌、胰腺癌和前列腺癌的新產品獲批等因素，實體腫瘤檢測市場正在擴大。

根據國際癌症研究機構（IARC）的估計，到2040年，全球癌症負擔預計將從2021年的190萬新病例達到2750萬新病例。此外，政府對癌症認知的不斷提高，以及發達的醫療基礎設施的存在，都在為市場創造有利的成長。此外，實體瘤檢測市場的發展還受到技術改進、若干產品的推出以及主要競爭對手的收購、合作和協議策略的推動。例如，羅氏公司在2021年8月宣布，VENTANA MMR RxDx Panel獲得了美國食品和藥物管理局（FDA）的批准，推進了該公司通過測試識別哪些患者最有可能從特定和目標療法中受益的個性化醫療承諾。 VENTANA MMR RxDx Panel是第一個幫助識別實體瘤在DNA錯配修復（dMMR）方面有缺陷的患者的輔助診斷測試。然而，在2023-2030年的預測期內，實體瘤檢測的高成本抑制了市場成長。

全球實體瘤檢測市場研究的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於重要市場參與者的普遍存在和該地區疾病頻率的增加，北美在收入方面主導了市場。另一方面，由於各種因素，如目標人口和老年人口的增加，產品開發合作的數量增加，主要參與者的地理擴張，以及非營利組織和政府組織對市場的積極參與，預計亞太地區在預測期內的年復合成長率最高。

本報告中包括的主要市場參與者有：

  • 齊根公司
  • 奎斯特診斷公司
  • 阿博特實驗室
  • 安捷倫科技公司
  • Biocare Medical LLC
  • F.霍夫曼-羅氏公司
  • Illumina, Inc.
  • MedGenome Labs Private Ltd
  • Myriad Genetics, Inc.
  • 賽默飛世爾科技公司

市場的最新發展：

  • 2022年12月，領先的生物技術公司DragonFly Therapeutics, Inc.報告說，HER2靶向TriNKET在晚期實體瘤患者中的2期研究已經給第一個病人用藥。
  • 2022年11月，CatalYm c宣布，它籌集了5477萬美元，以促進其實體瘤試驗和開發新的測試。

全球實體瘤檢測市場報告範圍：

  • 歷史數據： 2020 - 2021
  • 估計的基準年： 2022年
  • 預測期： 2023-2030年
  • 報告涵蓋範圍：收入預測，公司排名，競爭格局，成長因素，和趨勢
  • 覆蓋的細分市場：類型、應用、終端使用地區
  • 區域範圍：北美; 歐洲; 亞太地區; 拉丁美洲; 中東和非洲
  • 定製範圍：購買後可免費定製報告（相當於8個分析員的工作時間）。增加或改變國家、區域和部門範圍*。
  • 本研究的目的是確定近年來不同細分市場和國家的市場規模，並對未來幾年的價值進行預測。該報告旨在將研究涉及的國家內的行業的品質和數量方面都涵蓋其中。

該報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來成長。此外，它還涵蓋了微觀市場的潛在機會，供利益相關者投資，並詳細分析了競爭格局和主要參與者的產品。 .

目錄

第一章：執行摘要

  • 市場簡介
  • 2020-2030年全球及細分市場的估計和預測
    • 2020-2030年，按地區分類的實體瘤檢測市場
    • 2020-2030年，按類型分類的實體瘤檢測市場
    • 2020-2030年，按應用分類的實體瘤檢測市場
    • 2020-2030年，按終端用途分類的實體瘤檢測市場
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章：全球實體瘤檢測市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 行業演變
    • 研究的範圍
  • 研究涵蓋的年份
  • 貨幣兌換率

第三章：全球實體瘤檢測市場動態

  • 固體腫瘤檢測市場影響分析（2020-2030年）
    • 市場驅動力
      • 癌症的發病率不斷提高
      • 卵巢癌、胰腺癌和前列腺癌的新產品獲批。
    • 市場挑戰
      • 實體腫瘤檢測的高成本
    • 市場機會
      • 政府為提高癌症意識而採取的措施越來越多
      • 個性化治療的不斷發展
      • 發達的醫療基礎設施的存在

第四章：全球實體瘤檢測市場行業分析

  • 波特五力模型
    • 供應商的議價能力
    • 買方的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力影響分析
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術
    • 環境
    • 法律問題
  • 最佳投資機會
  • 最佳策略
  • COVID-19影響分析
  • 顛覆性趨勢
  • 行業專家的觀點
  • 分析師建議與結論

第五章：全球實體瘤檢測市場，按類型分類

  • 市場簡介
  • 按類型分類的全球實體瘤檢測市場，性能-潛力分析
  • 2020-2030年全球實體瘤檢測市場按類型的估計和預測
  • 固體腫瘤檢測市場，細項分析
    • 基因測試
    • 常規測試

第6章：全球實體瘤檢測市場，按應用分類

  • 市場簡介
  • 全球實體瘤檢測市場，按應用，性能-潛力分析
  • 2020-2030年全球實體瘤檢測市場按應用估計和預測的情況
  • 固體腫瘤檢測市場，細項分析
    • 前列腺
    • 乳腺
    • 大腸桿菌
    • 子宮內膜
    • 肺癌
    • 黑色素瘤
    • 腦癌
    • 其他

第7章：全球實體瘤檢測市場，按最終用途分類

  • 市場簡介
  • 全球實體瘤檢測市場，按終端用途，性能-潛力分析
  • 2020-2030年全球實體瘤檢測市場按終端用途的估計和預測
  • 固體腫瘤檢測市場，次級細分市場分析
    • 醫院
    • 製藥和生物技術公司
    • 契約研究組織
    • 學術研究機構

第八章：全球實體瘤檢測市場，區域分析

  • 最領先的國家
  • 新興國家
  • 固體腫瘤檢測市場，區域市場簡介
  • 北美洲
    • 美國
      • 2020-2030年類型細分的估計和預測
      • 2020-2030年，應用細分的估計和預測
      • 2020-2030年終端用途分類估計和預測
    • 加拿大
  • 歐洲實體瘤檢測市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區實體瘤檢測市場概況
    • 中國
    • 中國
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉丁美洲實體瘤檢測市場概況
    • 巴西
    • 墨西哥
  • 世界其他地區

第九章：競爭情報

  • 主要公司SWOT分析
    • 公司1
    • 公司二
    • 公司三
  • 頂級市場戰略
  • 公司簡介
    • Qiagen
      • 關鍵資訊
      • 概況
      • 財務（取決於數據的可用性）
      • 產品摘要
      • 近期發展情況
    • Quest Diagnostics Inc
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Biocare Medical LLC
    • F. Hoffmann-La Roche AG
    • Illumina, Inc.
    • MedGenome Labs Private Ltd
    • Myriad Genetics, Inc.
    • Thermo Fisher Scientific, Inc

第十章：研究過程

  • 研究過程
    • 資料探勘
    • 數據分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Solid Tumor Testing Market is valued at approximately USD 25.47 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.0% over the forecast period 2023-2030. A solid tumour is characterized as an uncontrolled cell development that does not include fluids or cysts. For the early-stage diagnosis of tumors, solid tumour testing is used. Despite significant research into the biology of solid tumors and the development of tests for the detection of solid tumors, they remain one of the main causes of death. Genetic and conventional testing are the two methods used to diagnose solid tumors. The Solid Tumor Testing market is expanding because of factors such as the rising prevalence of cancer and new product approvals in ovarian, pancreatic, and prostate cancers.

The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), it is estimated worldwide burden of cancer is projected to reach 27.5 million new cases by 2040 from 1.9 million new cases in the year 2021. In addition, Increasing Government Initiatives for Cancer Awareness, and the presence of developed healthcare infrastructure are creating lucrative growth in the market. Moreover, the development of the solid tumour testing market is also fueled by technical improvements, the introduction of several products, and key competitors' acquisition, partnership, and agreement tactics. For instance, Roche announced in August 2021 that the VENTANA MMR RxDx Panel has received approval from the U.S. Food and Drug Administration (FDA), advancing the company's commitment to personalized healthcare through tests that identify which patients are most likely to benefit from particular and targeted therapies. The first companion diagnostic test to help with patient identification whose solid tumors are defective in DNA mismatch repair (dMMR) is the VENTANA MMR RxDx Panel. However, the high cost of Solid Tumor Testing stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Solid Tumor Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue due to the prevalence of important market players and the increased frequency of diseases in the area. On the other hand, the Asia Pacific region is projected to have the highest CAGR during the forecast period due to a variety of factors, such as an increase in the target and geriatric populations, an increase in the number of product development collaborations, the geographic expansion of major players, and active participation by nonprofit and governmental organisations in the market..

Major market player included in this report are:

  • Qiagen
  • Quest Diagnostics Inc
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Biocare Medical LLC
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • MedGenome Labs Private Ltd
  • Myriad Genetics, Inc.
  • Thermo Fisher Scientific, Inc

Recent Developments in the Market:

  • In December 2022, Leading biotechnology firm DragonFly Therapeutics, Inc. reported that the Phase-2 research of HER2 targeting TriNKET in patients with advanced solid tumors had dosed its first patient.
  • In November 2022, CatalYm c announced it raised USD 54.77 million to boost its solid tumor trials and develop new testing.

Global Solid Tumor Testing Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Application, End Use Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East& Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
  • The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Genetic Testing
  • Conventional Testing

By Application:

  • Prostate
  • Breast
  • Colorectal
  • Endometrial
  • Lung
  • Melanoma
  • Brain
  • Others

By End Use:

  • Hospitals
  • Pharmaceutical and biotechnology companies
  • Contract research organizations
  • Academic research institutions

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Solid Tumor Testing Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Solid Tumor Testing Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Solid Tumor Testing Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Solid Tumor Testing Market, by End Use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Solid Tumor Testing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Solid Tumor Testing Market Dynamics

  • 3.1. Solid Tumor Testing Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of cancer
      • 3.1.1.2. New product approvals in ovarian, pancreatic, and prostate cancers.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Solid Tumor Testing
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing Government Initiatives for Cancer Awareness
      • 3.1.3.2. Rising development of personalised treatment
      • 3.1.3.3. Presence of developed healthcare infrastructure

Chapter 4. Global Solid Tumor Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Solid Tumor Testing Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Solid Tumor Testing Market by Type, Performance - Potential Analysis
  • 5.3. Global Solid Tumor Testing Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Solid Tumor Testing Market, Sub Segment Analysis
    • 5.4.1. Genetic Testing
    • 5.4.2. Conventional Testing

Chapter 6. Global Solid Tumor Testing Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Solid Tumor Testing Market by Application, Performance - Potential Analysis
  • 6.3. Global Solid Tumor Testing Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Solid Tumor Testing Market, Sub Segment Analysis
    • 6.4.1. Prostate
    • 6.4.2. Breast
    • 6.4.3. Colorectal
    • 6.4.4. Endometrial
    • 6.4.5. Lung
    • 6.4.6. Melanoma
    • 6.4.7. Brain
    • 6.4.8. Others

Chapter 7. Global Solid Tumor Testing Market, by End Use

  • 7.1. Market Snapshot
  • 7.2. Global Solid Tumor Testing Market by End Use, Performance - Potential Analysis
  • 7.3. Global Solid Tumor Testing Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
  • 7.4. Solid Tumor Testing Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Pharmaceutical and biotechnology companies
    • 7.4.3. Contract research organizations
    • 7.4.4. Academic research institutions

Chapter 8. Global Solid Tumor Testing Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Solid Tumor Testing Market, Regional Market Snapshot
  • 8.4. North America Solid Tumor Testing Market
    • 8.4.1. U.S. Solid Tumor Testing Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Solid Tumor Testing Market
  • 8.5. Europe Solid Tumor Testing Market Snapshot
    • 8.5.1. U.K. Solid Tumor Testing Market
    • 8.5.2. Germany Solid Tumor Testing Market
    • 8.5.3. France Solid Tumor Testing Market
    • 8.5.4. Spain Solid Tumor Testing Market
    • 8.5.5. Italy Solid Tumor Testing Market
    • 8.5.6. Rest of Europe Solid Tumor Testing Market
  • 8.6. Asia-Pacific Solid Tumor Testing Market Snapshot
    • 8.6.1. China Solid Tumor Testing Market
    • 8.6.2. India Solid Tumor Testing Market
    • 8.6.3. Japan Solid Tumor Testing Market
    • 8.6.4. Australia Solid Tumor Testing Market
    • 8.6.5. South Korea Solid Tumor Testing Market
    • 8.6.6. Rest of Asia Pacific Solid Tumor Testing Market
  • 8.7. Latin America Solid Tumor Testing Market Snapshot
    • 8.7.1. Brazil Solid Tumor Testing Market
    • 8.7.2. Mexico Solid Tumor Testing Market
  • 8.8. Rest of The World Solid Tumor Testing Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Qiagen
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Quest Diagnostics Inc
    • 9.3.3. Abbott Laboratories
    • 9.3.4. Agilent Technologies Inc.
    • 9.3.5. Biocare Medical LLC
    • 9.3.6. F. Hoffmann-La Roche AG
    • 9.3.7. Illumina, Inc.
    • 9.3.8. MedGenome Labs Private Ltd
    • 9.3.9. Myriad Genetics, Inc.
    • 9.3.10. Thermo Fisher Scientific, Inc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Solid Tumor Testing Market, report scope
  • TABLE 2. Global Solid Tumor Testing Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Solid Tumor Testing Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Solid Tumor Testing Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Solid Tumor Testing Market estimates & forecasts by End Use 2020-2030 (USD Billion)
  • TABLE 6. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Solid Tumor Testing Market
  • TABLE 71. List of primary sources, used in the study of global Solid Tumor Testing Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Solid Tumor Testing Market, research methodology
  • FIG 2. Global Solid Tumor Testing Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Solid Tumor Testing Market, key trends 2022
  • FIG 5. Global Solid Tumor Testing Market, growth prospects 2023-2030
  • FIG 6. Global Solid Tumor Testing Market, porters 5 force model
  • FIG 7. Global Solid Tumor Testing Market, pest analysis
  • FIG 8. Global Solid Tumor Testing Market, value chain analysis
  • FIG 9. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Solid Tumor Testing Market, regional snapshot 2020 & 2030
  • FIG 15. North America Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Solid Tumor Testing Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable